Advancing Targeted In Vivo LNPs: Five Practical Considerations To Move From Concept To Clinic

Targeted in vivo delivery is reshaping genetic medicine, but moving from concept to clinic requires navigating complex technical and regulatory challenges. Success depends on decisions made early, from selecting the right formulation and conjugation strategies to ensuring bioanalytical readiness and managing process complexity. This webinar brings together expert insights on five critical considerations for advancing lipid nanoparticle (LNP) programs, drawing on lessons from ARPA-H-funded initiatives and real-world collaborations. Gain a practical framework for designing in vivo programs that are robust, scalable, and clinically viable.

If you’re looking to accelerate development and avoid common pitfalls, learn about strategies to help your team move forward with confidence.